Success Metrics

Clinical Success Rate
81.5%

Based on 592 completed trials

Completion Rate
82%(592/726)
Active Trials
681(41%)
Results Posted
45%(269 trials)
Terminated
134(8%)

Phase Distribution

Ph phase_1
134
8%
Ph phase_4
18
1%
Ph not_applicable
638
39%
Ph early_phase_1
37
2%
Ph phase_3
147
9%
Ph phase_2
388
24%

Phase Distribution

171

Early Stage

388

Mid Stage

165

Late Stage

Phase Distribution1362 total trials
Early Phase 1First-in-human
37(2.7%)
Phase 1Safety & dosage
134(9.8%)
Phase 2Efficacy & side effects
388(28.5%)
Phase 3Large-scale testing
147(10.8%)
Phase 4Post-market surveillance
18(1.3%)
N/ANon-phased studies
638(46.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.0%

592 of 822 finished

Non-Completion Rate

28.0%

230 ended early

Currently Active

681

trials recruiting

Total Trials

1,647

all time

Status Distribution
Active(730)
Completed(592)
Terminated(230)
Other(95)

Detailed Status

Completed592
Recruiting355
Active, not recruiting326
Terminated134
Withdrawn96
unknown73

Development Timeline

Analytics

Development Status

Total Trials
1647
Active
681
Success Rate
81.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 137 (2.7%)
Phase 1134 (9.8%)
Phase 2388 (28.5%)
Phase 3147 (10.8%)
Phase 418 (1.3%)
N/A638 (46.8%)

Trials by Status

suspended221%
not_yet_recruiting473%
terminated1348%
completed59236%
enrolling_by_invitation20%
recruiting35522%
unknown734%
active_not_recruiting32620%
withdrawn966%

Recent Activity

Clinical Trials (1,647)

Showing 20 of 1,647 trialsScroll for more
NCT02918474Not Applicable

Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Recruiting
NCT06568172Phase 3

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

Recruiting
NCT07278739Not Applicable

Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams

Not Yet Recruiting
NCT02615275Not Applicable

Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy

Active Not Recruiting
NCT03674229Not Applicable

Patients Navigators in Facilitating Weight Management in Obese Participants

Active Not Recruiting
NCT05642611Phase 3

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

Recruiting
NCT05026983Phase 2

Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases

Recruiting
NCT03145077Not Applicable

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body

Recruiting
NCT05035667

Patient Considerations of Social Media Account Management After Death

Active Not Recruiting
NCT04595422Not Applicable

Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines

Recruiting
NCT02863107

Young-Onset Colorectal Cancer

Active Not Recruiting
NCT03418038Phase 2

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Recruiting
NCT04125914Not Applicable

Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families

Active Not Recruiting
NCT02543320Not Applicable

Neurofeedback in Decreasing Acute Radiotherapy-Induced Pain in Patients With Head and Neck Cancer

Active Not Recruiting
NCT04783168Not Applicable

Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study

Recruiting
NCT02131584Phase 2

Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia

Active Not Recruiting
NCT04267796Not Applicable

Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women

Active Not Recruiting
NCT03574792Phase 2

Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy

Completed
NCT01627093

Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy

Active Not Recruiting
NCT04829539Phase 3

Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
1,647